I'm all for it in almost every area. But it does seem to me that, in healthcare, it may generate amazing new drugs and treatments, but it sure doesn't add up to what we normally think of as market efficiency:
Maybe this is just a cultural function of Americans' preference for costly and inefficient medicine over cheaper, more efficient models. But American consumers are usually pretty good at keeping prices in line. In healthcare? For various reasons, it doesn't seem to work. More on that theme at the Economist.
The Dish 